<?xml version="1.0" ?>
<document id="e0bf08186f4d0b6112d6f4b8535584739da35596">
  <chunk id="e0bf08186f4d0b6112d6f4b8535584739da35596.c0" text="Canine morbillivirus (canine distemper virus) with concomitant canine adenovirus, canine parvovirus-2, and Neospora caninum in puppies: a retrospective immunohistochemical study OPEN"/>
  <chunk id="e0bf08186f4d0b6112d6f4b8535584739da35596.c1" text="A retrospective immunohistochemical study was designed to investigate the frequency of concomitant traditional infectious disease pathogens in puppies that died suddenly and review the aspects of associated pathogenesis. Fifteen puppies were evaluated; the pathology reports and histopathologic slides of these animals were reviewed to determine the pattern of histopathologic lesions. The intralesional identification of antigens of canine (distemper) morbillivirus (CDV), canine adenovirus-1 and -2 (CAdV-1 and -2), canine parvovirus-2 (CPV-2), Toxoplasma gondii, and Neospora caninum was evaluated by IHC within the histopathologic patterns observed. All puppies contained CDV nucleic acid by molecular testing. The most frequent histopathologic patterns were intestinal crypt necrosis (n = 8), white matter cerebellar demyelination (n = 7), necrohaemorrhagic hepatitis (n = 7), interstitial pneumonia (n = 7), and gallbladder oedema (n = 5). All puppies contained intralesional antigens of CDV in multiple tissues resulting in singular (n = 3), and concomitant dual (n = 3), triple (n = 5) and quadruple (n = 4) infections by CAdV-1, and -2, CPV-2, and N. caninum; T. gondii was not identified. Concomitant infections by CDV was observed with N. caninum (100%; 1/1), CPV-2 (100%; 8/8), CAdV-1 (100%; 8/8), and CAdV-2 (100%; 8/8). Intralesional antigens of CDV and not CAdV-1 were identified in cases of gallbladder oedema. The &quot;blue eye&quot; phenomenon was histologically characterized by corneal oedema and degenerative lesions to the corneal epithelium, without inflammatory reactions.">
    <entity charOffset="74-83" id="e0bf08186f4d0b6112d6f4b8535584739da35596.c1.e0" ontology_id="HP_0040279" text="frequency" type="phenotype"/>
    <entity charOffset="724-732" id="e0bf08186f4d0b6112d6f4b8535584739da35596.c1.e1" ontology_id="HP_0040282" text="frequent" type="phenotype"/>
    <entity charOffset="780-788" id="e0bf08186f4d0b6112d6f4b8535584739da35596.c1.e2" ontology_id="GO_0001906" text="necrosis" type="gene_function"/>
    <entity charOffset="822-835" id="e0bf08186f4d0b6112d6f4b8535584739da35596.c1.e3" ontology_id="HP_0011096" text="demyelination" type="phenotype"/>
    <entity charOffset="863-872" id="e0bf08186f4d0b6112d6f4b8535584739da35596.c1.e4" ontology_id="HP_0012115" text="hepatitis" type="phenotype"/>
    <entity charOffset="895-904" id="e0bf08186f4d0b6112d6f4b8535584739da35596.c1.e5" ontology_id="HP_0002090" text="pneumonia" type="phenotype"/>
    <entity charOffset="930-936" id="e0bf08186f4d0b6112d6f4b8535584739da35596.c1.e6" ontology_id="HP_0000969" text="oedema" type="phenotype"/>
    <entity charOffset="1419-1425" id="e0bf08186f4d0b6112d6f4b8535584739da35596.c1.e7" ontology_id="HP_0000969" text="oedema" type="phenotype"/>
    <entity charOffset="1497-1503" id="e0bf08186f4d0b6112d6f4b8535584739da35596.c1.e8" ontology_id="HP_0000969" text="oedema" type="phenotype"/>
    <pair e1="e0bf08186f4d0b6112d6f4b8535584739da35596.c1.e0" e2="e0bf08186f4d0b6112d6f4b8535584739da35596.c1.e2" id="e0bf08186f4d0b6112d6f4b8535584739da35596.c1.p0" relation="true"/>
    <pair e1="e0bf08186f4d0b6112d6f4b8535584739da35596.c1.e1" e2="e0bf08186f4d0b6112d6f4b8535584739da35596.c1.e2" id="e0bf08186f4d0b6112d6f4b8535584739da35596.c1.p1" relation="true"/>
    <pair e1="e0bf08186f4d0b6112d6f4b8535584739da35596.c1.e2" e2="e0bf08186f4d0b6112d6f4b8535584739da35596.c1.e3" id="e0bf08186f4d0b6112d6f4b8535584739da35596.c1.p2" relation="true"/>
    <pair e1="e0bf08186f4d0b6112d6f4b8535584739da35596.c1.e2" e2="e0bf08186f4d0b6112d6f4b8535584739da35596.c1.e4" id="e0bf08186f4d0b6112d6f4b8535584739da35596.c1.p3" relation="true"/>
    <pair e1="e0bf08186f4d0b6112d6f4b8535584739da35596.c1.e2" e2="e0bf08186f4d0b6112d6f4b8535584739da35596.c1.e5" id="e0bf08186f4d0b6112d6f4b8535584739da35596.c1.p4" relation="true"/>
    <pair e1="e0bf08186f4d0b6112d6f4b8535584739da35596.c1.e2" e2="e0bf08186f4d0b6112d6f4b8535584739da35596.c1.e6" id="e0bf08186f4d0b6112d6f4b8535584739da35596.c1.p5" relation="true"/>
    <pair e1="e0bf08186f4d0b6112d6f4b8535584739da35596.c1.e2" e2="e0bf08186f4d0b6112d6f4b8535584739da35596.c1.e7" id="e0bf08186f4d0b6112d6f4b8535584739da35596.c1.p6" relation="true"/>
    <pair e1="e0bf08186f4d0b6112d6f4b8535584739da35596.c1.e2" e2="e0bf08186f4d0b6112d6f4b8535584739da35596.c1.e8" id="e0bf08186f4d0b6112d6f4b8535584739da35596.c1.p7" relation="true"/>
  </chunk>
  <chunk id="e0bf08186f4d0b6112d6f4b8535584739da35596.c2" text="Canine morbillivirus (canine distemper virus, CDV) causes canine distemper (CD) in a wide range of mammalian hosts, and may produce systemic, respiratory, cutaneous, bone, and/or neurological manifestations in these animals 1,2 . CDV produces immunosuppression 3 in susceptible hosts by targeting cells that express the signalling activation molecule (SLAM) 4 , which frequently results in opportunistic infectious diseases caused by agents such as Bordetella bronchiseptica 5,6 , Candida sp. 7 , Clostridium piliforme 8 , Toxoplasma gondii 9-11 , Dirofilaria immitis 11 , Mycoplasma cynos 12 , and Talaromyces marneffei 13 . Although the occurrence of CD is significantly reduced in domestic dog populations in developed countries due to the use of vaccination 14 , the disease is endemic and a">
    <entity charOffset="320-330" id="e0bf08186f4d0b6112d6f4b8535584739da35596.c2.e0" ontology_id="GO_0023052" text="signalling" type="gene_function"/>
  </chunk>
</document>
